Related Experiment Video
Updated: May 19, 2026
07:18
A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice
Published on: March 2, 2019
Neurodegenerative Disease and REM Behavior Disorder
Raman Malhotra1, Alon Y Avidan
1SLUCare Sleep Disorders Center, Department of Neurology and Psychiatry, Saint Louis University School of Medicine, 1438 South Grand Boulevard, St. Louis, MO, 63104, USA, rmalhot1@slu.edu.
Current Treatment Options in Neurology
|August 11, 2012
Summary
Sleep disorders are common in cerebral degenerative conditions and impact quality of life. Effective management requires accurate diagnosis and targeted therapies like CPAP for sleep apnea and behavioral strategies for insomnia.
Area of Science:
- Neurology
- Sleep Medicine
- Geriatrics
Background:
- Cerebral degenerative conditions frequently present with diverse sleep disorders, including sleep-disordered breathing, insomnia, REM sleep behavior disorder, circadian rhythm disturbances, and restless legs syndrome.
- Unmanaged sleep disorders exacerbate neurological symptoms and diminish patients' quality of life.
Purpose of the Study:
- To outline the diagnostic and therapeutic strategies for managing common sleep disorders in patients with cerebral degenerative conditions.
Main Methods:
- Clinical history taking from patients and bed partners.
- Polysomnography for diagnosing sleep-disordered breathing and parasomnias.
- Review of pharmacological and non-pharmacological treatment options for various sleep disorders.
Main Results:
- Specific treatments include continuous positive airway pressure (CPAP) for sleep apnea, behavioral therapies for insomnia, safety precautions and medication for REM sleep behavior disorder, and iron replacement or dopamine agonists for restless legs syndrome.
- Light therapy may benefit circadian rhythm disorders.
- Medication adjustments and improved sleep hygiene can offer some relief, but often specific interventions are necessary.
Conclusions:
- Addressing sleep disorders is crucial for improving the well-being of individuals with cerebral degenerative conditions.
- Tailored therapeutic interventions, ranging from CPAP to behavioral strategies and specific medications, are essential for effective management.
- Further research into pharmacological treatments for insomnia in this population is warranted due to potential side effects and limited data.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...